| 1. |
- Azzu, V., et al.
(författare)
-
Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression
- 2021
-
Ingår i: Molecular Metabolism. - : Elsevier BV. - 2212-8778. ; 48
-
Tidskriftsartikel (refereegranskat)abstract
- Objective: Non-alcoholic fatty liver disease (NAFLD) is a silent pandemic associated with obesity and the metabolic syndrome, and also increases cardiovascular- and cirrhosis-related morbidity and mortality. A complete understanding of adaptive compensatory metabolic programmes that modulate non-alcoholic steatohepatitis (NASH) progression is lacking. Methods and results: Transcriptomic analysis of liver biopsies in patients with NASH revealed that NASH progression is associated with rewiring of metabolic pathways, including upregulation of de novo lipid/cholesterol synthesis and fatty acid remodelling. The modulation of these metabolic programmes was achieved by activating sterol regulatory element-binding protein (SREBP) transcriptional networks; however, it is still debated whether, in the context of NASH, activation of SREBPs acts as a pathogenic driver of lipotoxicity, or rather promotes the biosynthesis of protective lipids that buffer excessive lipid accumulation, preventing inflammation and fibrosis. To elucidate the pathophysiological role of SCAP/SREBP in NASH and wound-healing response, we used an Insig1 deficient (with hyper-efficient SREBPs) murine model challenged with a NASH-inducing diet. Despite enhanced lipid and cholesterol biosynthesis, Insig1 KO mice had similar systemic metabolism and insulin sensitivity to Het/WT littermates. Moreover, activating SREBPs resulted in remodelling the lipidome, decreased hepatocellular damage, and improved wound-healing responses. Conclusions: Our study provides actionable knowledge about the pathways and mechanisms involved in NAFLD pathogenesis, which may prove useful for developing new therapeutic strategies. Our results also suggest that the SCAP/SREBP/INSIG1 trio governs transcriptional programmes aimed at protecting the liver from lipotoxic insults in NASH. (C) 2021 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
|
|
| 2. |
- Razzak, S. B. A., et al.
(författare)
-
Quantitative and qualitative assessments of microbial contamination in some bottled and tap water with their drug resistant pattern
- 2021
-
Ingår i: International Food Research Journal. - 1985-4668. ; 28:5, s. 945-952
-
Tidskriftsartikel (refereegranskat)abstract
- The present work focussed on the concerns of the existence of coliform, faecal coliform, and other pathogens in both tap water and commercially available bottled water, along with the drug resistant pattern of the isolates. The physico-chemical features of the bottled water samples were satisfactory, but most of the tap water exceeded the marginal limit. A total of 21 samples (10 of tap water and 11 of bottled water) were collected and processed for microbiological analysis. All the samples were found to be contaminated with total viable bacteria up to 10(8) CFU/mL. Among the 21 samples, seven samples were found to be contaminated with E. coli up to 10(6) CFU/mL, and six samples had Klebsiella spp. up to 10(2) CFU/mL. Faecal contamination was totally absent in all bottled water, but present in four tap water samples. Fungi was found in six samples within the range of 10(2) to 10(3) CFU/mL. Surprisingly, Staphylococcus spp. were observed in all bottled water. Vibrio spp. were detected in three samples. An elevated number of faecal coliforms, Klebsiella spp., Salmonella spp., Shigella spp., Vibrio spp., and Pseudomonas spp. were estimated among the tap water samples up to 10(5) CFU/mL. The water samples, especially tap water, collected from the different areas were microbiologically unsafe, as few pathogenic microorganisms were found in several samples. This indicated as public health threat. Most of the isolates from both tap and bottled water samples were found to be resistant against more than one antibiotic tested, which is extremely alarming for the consumers. Very few antibiotics were found to be effective against the bacterial isolates. (C) All Rights Reserved.
|
|
| 3. |
|
|
